Skip to main content
. Author manuscript; available in PMC: 2012 Jul 29.
Published in final edited form as: Neuron. 2011 Jun 23;70(6):1033–1053. doi: 10.1016/j.neuron.2011.06.003

Table 2.

Type Inh. Gene Chromosome
Alzheimer disease (AD)
AD1 AD APP 21q21.3
AD2 ? APOE 19q 13.32
AD3 AD PSEN1 14q24.2
AD4 AD PSEN2 1q4213
AD5 ? ? 12p11-q13
AD6 ? ? 10q 24
AD 7 ? ? 10p13
AD8 ? ? 20p
AD9 ? ? 19p13.2
AD10 ? ? 7q36
AD11 ? ? 9p21.3
AD12 ? ? 8p12-q22
AD13 ? ? 1q21
AD14 ? ? 1q25
AD15 ? ? 3q22-q24
AD16 XL ? Xq 21.3
Amyotrophic lateral sclerosis ( ALS)
ALS1 AD SOD1 21q 22.11
ALS2 (J) AR ALS2 2q33.1
ALS3 AD ? 18q 21
ALS4 (J) AD SETX 9q34.13
ALS5 AR ? 15q15-q21
ALS6 AR FUS 16p11.2
ALS7 AD ? 20p13
ALS8 AD VAPB 20q 13.32
ALS9 AD ANG 14q11.2
ALS10 AD TARDBP 1p36.22
ALS11 AD FIG4 6q21
ALS12 AD/AR OPTN 10p13
ALS13 AD ATXN2 12q 24.12
? AR SPG11 15q21.1
? AD VCP 9p13.3
Charcot-Marie-Tooth disease ( CMT)
CMT1A AD PM P22 17p12
CMT1B AD MPZ 1q23.3
CMT1C AD LITAF 16p13.13
CMT1D AD EGR2 10q 21.3
CMT1F AD NEFL 8p21.2
CMT2A1 AD KIF1B 1p36.22
CM T2A2 AD MFN2 1p36.22
CM T2B AD RAB7A 3q21.3
CMT2B1 AR LMNA 1q22
CM T2B2 AR MED25 19q 13.33
CM T2C AD TR PV4 12q 24.11
CM T2D AD GARS 7p14.3
CM T2E AD NEFL 8p21.2
CM T2F AD/AR HSPB1 7q11.23
CM T2G AD ? 12q12-q13.3
CM T2H AR ? 8q21 3
CM T2I AD MPZ 1q23.3
CM T2J AD MPZ 1q23.3
CM T2K AD GDAP1 8q21.11
CM T2L AD HSPB8 12q 24.23
CM T2M AD DN M2 19p13.2
CM T2N AD AARS 16q 22.1
CM T4A AR GDAP1 8q21.11
CMT4B1 AR MTMR2 11q 21
CM T4B2 AR SBF2 11p15.4
CM T4C AR SH 3TC2 5q32
CM T4D AR NDRG1 8q24.22
CM T4E AD/AR EGR2 10q 21.3
CM T4F AR PR X 19q 13.2
CM T4G AR ? 10q 23.2
CM T4H AR FGD4 12p1121
CM T4J AR F G4 6q21
CM TDIA AD ? 10q24.1-q25.1
CM TDIB AD DN M2 19p13.2
CM TDIC AD YARS 1p35.1
CM TX1 XL GJB1 Xq 13 1
Huntington disease (HD)
HD AD HTT 4p16 3
Hereditary spastic paraplegia ( HSP)
SPG1 XL L1CAM Xq 28
SPG2 XL PLP1 Xq 22
SPG3A AD ATL1 14q 22 1
SPG4 AD SPAST 2p22 3
SPG5A AR CYP7B1 8q12 3
SPG6 AD NIPA1 15q112
SPG7 AR SPG7 16q 24 3
SPG8 AD KIAA0196 8q24.13
SPG9 AD ? 10q 23.3-q24.1
SPG10 AD KIF5A 12q 13.3
SPG11 AR SPG11 15q21.1
SPG12 AD ? 19q13.11-q 13.13
SPG13 AD HSPD1 2q33.1
SPG14 AR ? 3q27-q28
SPG15 AR ZFYVE26 14q 24.1
SPG16 XL ? Xq11.2
SPG17 AD BSCL2 11q 12.3
SPG18 AR ? 8p12-p11.21
SPG19 AD ? 9q33-q34
SPG20 AR SPG20 13q 13.3
SPG21 AR SPG21 15q 22.31
SPG22 XL SLC16A2 Xq 13.2
SPG23 AR ? 1q24- q32
SPG24 AR ? 13q 14.3
SPG25 AR ? 6q23.3-q24.1
SPG26 AR ? 12p11.1-q15
SPG27 AR ? 10q 22 1-q24 1
SPG28 AR ? 14q 21.3-q22.3
SPG29 AD ? 1p31.1-p21.1
SPG30 AR ? 2q37 3
SPG31 AD REEP1 2p11.2
SPG32 AR ? 14q12-q21
SPG33 AD ZFYVE27 10q 24.2
SPG34 XL ? Xq24-q25
SPG35 AR ? 16q 21-q 23.1
SPG36 AD ? 12q 23-q 24
SPG37 AD ? 8p21.1-q13.3
SPG38 AD ? 4p16-p15
SPG39 AR PN PLA6 19p13 2
SPG40 AD ATL1 14q 22.1
SPG41 AD ? 11p14.1-p11.2
SPG42 AD SLC33A1 3q25.31
SPG44 AR GJC2 1q42 13
SPG45 AR ? 10q24.3-q25.1
? AR AIMP1 4q24
Optic atrophy( OA)
OPA1 AD OPA1 3q29
OPA2 XL ? Xp11.4-p11.21
OPA3 AD OPA3 19q 13 32
OPA4 AD ? 18q12.2-q123
OPA5 ADAR ? 22q12.1-q13.1
OPA6 AR ? 8q21 13-q22 1
OPA7 AR TM EM126 A 11q 14.1
LHON M ND genes mtDNA
Parkinson disease ( PD))
PARK1/4 AD SN CA 4q22.1
PARK2 AR PARK2 6q26
PARK3 AD ? 2p13
PARK5 AD UCHL1 4p13
PARK6 AR PIN K1 1p36 12
PARK7 AR PARK7/Park in 1p36 23
PARK8 AD LRRK2 12q 12
PARK9 AR ATP13A2 1p36 13
PARK10 ? ? 1p32
PARK11 AD GIGYF2 2q37 1
PARK12 ? ? Xq21-q25
PARK13 ? HTRA2 2p13 1
PARK14 ? PLA2G6 22q 13 1
PARK15 AR FBXO7 22q 12 3
PARK16 ? ? 1q32
? AR SPG11 15q21.1
? AR NDUFV2 18p11 22
Spinocerebellar ataxia ( SCA)
SCA1 AD ATXN1 6p22.3
SCA2 AD ATXN2 12q 24.12
SCA3 AD ATXN3 14q 32.12
SCA4 AD PLEKHG4 16q 22.1
SCA5 AD SPTBN2 11q 13.2
SCA6 AD CACNA1A 19p13.2
SCA7 AD ATXN7 3p14.1
SCA8 AD ATXN8 13q 21.33
SCA8 AD ATXN 8OS 13q 21.33
SCA9 AD ? ?
SCA10 AD ATXN10 22q 13.31
SCA11 AD TTBK2 15q15.2
SCA12 AD PPP2R2B 5q32
SCA13 AD KCNC3 19q 13.33
SCA14 AD PR KCG 19q 13.42
SCA15 AD ITPR1 3p26.1
SCA16 AD CN TN4 3p26.2
SCA17 AD TBP 6q27
SCA18 AD ? 7q22-q23
SCA19 AD ? 1p21-q21
SCA20 AD ? 11p13-q 11
SCA21 AD ? 7p21.3-p15.1
SCA22 AD ? 1p21-q23
SCA23 AD ? 20p13-p12.3
SCA24 AR ? 1p36
SCA25 AD ? 2p21-p13
SCA26 AD ? 19p13.3
SCA27 AD FGF14 13q 33.1
SCA28 AR AFG3L2 18p11.21
SCA29 AD ? 3p26
SCA30 AD ? 4q34.3-q35.1
SCA31 AD BEAN -TK2 16q 21
SCAN1 AR TDP1 14q 32.1
SCAR1 AR SETX 9q34.13
SCAR2 AR ? 9q34-qter
SCAR3 AR ? 6p23-p21
SCAR4 AR ? 1p36
SCAR5 AR ? 15q25.3
SCAR6 AR ? 20q 11-q 13
SCAR7 AR ? 11p15
SCAR8 AR SYNE1 6q25.2
SCAR9 AR ADCK3 1q42 13
SCAX1 XL ? Xp11 21-q21 3
DR PLA AD ATN1 12p13 31
FR DA1 AR FXN 9q21 11
FR DA2 AR ? 9p23-p11
IOSCA AR C10orl2 10q 24 31
MIRAS AR POLG 15q26.1
? AR AN O10 3p22 1
? AD SCN8A 12q 13.3

Disease classification as listed in OMIM. Inh., Inheritance. AD, autosomal dominant; AR, autosomal recessive; M, mitochondrial; XL, X-linked.